07:28 AM EDT, 03/11/2026 (MT Newswires) -- Kala Bio ( KALA ) said Wednesday that its Researgency.ai platform is now live, with the first artificial intelligence agent expected to be deployed in about 14 days.

The platform will allow enterprises to design, deploy, and improve AI agents that can automate tasks including research monitoring, clinical trial documentation, regulatory filing, and drug safety reporting, the company said.

Kala said it is building the first AI agent together with Younet's AI engineering team.

Shares of Kala were up 65% pre-bell Wednesday.